Faculty profile
Carly Barron
Back to facultyResearch
Read how they describe their research on their University of Toronto profile.
Latest papers
External Beam Radiotherapy in the Management of Differentiated Thyroid Cancer: A Single Institution Retrospective Cohort Review.
Practical radiation oncology · 2026
Insights and advances in chronic urticaria: a Canadian perspective
Allergy, Asthma & Clinical Immunology · 2015
Real-life experiences with omalizumab for the treatment of chronic urticaria.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2014
Latest funding
- $2,995,962
A randomized phase II study of ramucirumab and paclitaxel +/- zanidatamab in HER2 overexpressing advanced gastroesophageal adenocarcinoma
CIHR · 2022 · Co-investigator
- $748,990
A randomized phase II study of ramucirumab and paclitaxel +/- zanidatamab in HER2 overexpressing advanced gastroesophageal adenocarcinoma
CIHR · 2022 · Co-investigator
3 publications.
External Beam Radiotherapy in the Management of Differentiated Thyroid Cancer: A Single Institution Retrospective Cohort Review.
Bartolucci D, Agarwal M, Ye XY, Adeoya D, Tsang RWC, Mete O, Madani A, Ma L, Barron C, Brierley J, Lukovic J, Mesci A
Insights and advances in chronic urticaria: a Canadian perspective
Sussman G, Hébert J, Gulliver W, Lynde C, Waserman S, Kanani A, Ben-Shoshan M, Horemans S, Barron C, Betschel S
Real-life experiences with omalizumab for the treatment of chronic urticaria.
Sussman G, Hébert J, Barron C, Bian J, Caron-Guay RM, Laflamme S, Stern S
A randomized phase II study of ramucirumab and paclitaxel +/- zanidatamab in HER2 overexpressing advanced gastroesophageal adenocarcinoma
Principal investigators: Elimova, Elena; Goodwin, Rachel A; Lim, Howard; O'Callaghan, Christopher J; Tu, Dongsheng
Keywords: Clinical Trial; Gastroesophageal Cancer; Her 2 Positive
A randomized phase II study of ramucirumab and paclitaxel +/- zanidatamab in HER2 overexpressing advanced gastroesophageal adenocarcinoma
Principal investigators: Elimova, Elena; Goodwin, Rachel A; Lim, Howard; O'Callaghan, Christopher J; Tu, Dongsheng
Keywords: Clinical Trial; Gastroesophageal Cancer; Her 2 Positive
From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.
Frequent collaborators
- Susan Waserman and Stephen Betschel: 21 shared papers
- Susan Waserman and Moshe Ben-Shoshan: 17 shared papers
- Jelena Lukovic and Aruz Mesci: 10 shared papers
- Moshe Ben-Shoshan and Stephen Betschel: 4 shared papers
- Jelena Lukovic and Ozgur Mete: 4 shared papers
- Jelena Lukovic and James Brierley: 4 shared papers
- Stephen Betschel and Gordon Sussman: 4 shared papers
- Ozgur Mete and Aruz Mesci: 4 shared papers
- Moshe Ben-Shoshan and Gordon Sussman: 3 shared papers
- Ozgur Mete and James Brierley: 3 shared papers
- Peter Vadas and Gordon Sussman: 3 shared papers
- Susan Waserman and Gordon Sussman: 2 shared papers
- Stephen Betschel and Peter Vadas: 2 shared papers
- Carly Barron and Gordon Sussman: 2 shared papers
- James Brierley and Aruz Mesci: 2 shared papers
- Susan Waserman and Jan Dutz: 1 shared paper
- Susan Waserman and Carly Barron: 1 shared paper
- Susan Waserman and Peter Vadas: 1 shared paper
- Jan Dutz and Moshe Ben-Shoshan: 1 shared paper
- Jan Dutz and Stephen Betschel: 1 shared paper
- Jan Dutz and Carly Barron: 1 shared paper
- Moshe Ben-Shoshan and Carly Barron: 1 shared paper
- Jelena Lukovic and Carly Barron: 1 shared paper
- Jelena Lukovic and Lucy Ma: 1 shared paper
- Jelena Lukovic and Amin Madani: 1 shared paper
- Stephen Betschel and Carly Barron: 1 shared paper
- Ozgur Mete and Carly Barron: 1 shared paper
- Ozgur Mete and Lucy Ma: 1 shared paper
- Ozgur Mete and Amin Madani: 1 shared paper
- Carly Barron and Peter Vadas: 1 shared paper
- Carly Barron and James Brierley: 1 shared paper
- Carly Barron and Aruz Mesci: 1 shared paper
- Carly Barron and Lucy Ma: 1 shared paper
- Carly Barron and Amin Madani: 1 shared paper
- Department of Medicine
- Department of Radiation Oncology
- Department of Surgery
- Department of Dermatology and Skin Science
- Department of Epidemiology, Biostatistics and Occupational Health
- Department of Laboratory Medicine & Pathobiology
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Gordon Sussman
Department of Medicine
2 shared papers, latest 2015
Peter Vadas
Department of Medicine
1 shared papers, latest 2015
James Brierley
Department of Radiation Oncology
1 shared papers, latest 2026
Aruz Mesci
Department of Radiation Oncology
1 shared papers, latest 2026
Lucy Ma
Department of Medicine
1 shared papers, latest 2026
Amin Madani
Department of Surgery
1 shared papers, latest 2026
Susan Waserman
Department of Medicine
1 shared papers, latest 2015
Jan Dutz
Department of Dermatology and Skin Science
1 shared papers, latest 2015
Moshe Ben-Shoshan
Department of Epidemiology, Biostatistics and Occupational Health
1 shared papers, latest 2015
Jelena Lukovic
Department of Radiation Oncology
1 shared papers, latest 2026
Stephen Betschel
Department of Medicine
1 shared papers, latest 2015
Ozgur Mete
Department of Laboratory Medicine & Pathobiology
1 shared papers, latest 2026
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.